METHYL 3-(BENZOYLAMINO)-6-METHYL-2-OXO-2H-PYRAN-5-CARBOXYLATE
- $181 - $524
- Product name: METHYL 3-(BENZOYLAMINO)-6-METHYL-2-OXO-2H-PYRAN-5-CARBOXYLATE
- CAS: 338404-89-0
- MF: C15H13NO5
- MW: 287.27
- EINECS:
- MDL Number:MFCD00139779
- Synonyms:METHYL 3-(BENZOYLAMINO)-6-METHYL-2-OXO-2H-PYRAN-5-CARBOXYLATE;2H-Pyran-5-carboxylic acid, 3-(benzoylamino)-6-methyl-2-oxo-, methyl ester
4 prices
Selected condition:
Brand
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- 5g
- ManufacturerCrysdot
- Product numberCD11141108
- Product descriptionMethyl3-benzamido-6-methyl-2-oxo-2H-pyran-5-carboxylate 95+%
- Packaging5g
- Price$325
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number044055
- Product descriptionMethyl 3-(benzoylamino)-6-methyl-2-oxo-2H-pyran-5-carboxylate >95%
- Packaging500mg
- Price$181
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number044055
- Product descriptionMethyl 3-(benzoylamino)-6-methyl-2-oxo-2H-pyran-5-carboxylate >95%
- Packaging1g
- Price$228
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number044055
- Product descriptionMethyl 3-(benzoylamino)-6-methyl-2-oxo-2H-pyran-5-carboxylate >95%
- Packaging5g
- Price$524
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11141108 | Methyl3-benzamido-6-methyl-2-oxo-2H-pyran-5-carboxylate 95+% | 5g | $325 | 2021-12-16 | Buy |
Matrix Scientific | 044055 | Methyl 3-(benzoylamino)-6-methyl-2-oxo-2H-pyran-5-carboxylate >95% | 500mg | $181 | 2021-12-16 | Buy |
Matrix Scientific | 044055 | Methyl 3-(benzoylamino)-6-methyl-2-oxo-2H-pyran-5-carboxylate >95% | 1g | $228 | 2021-12-16 | Buy |
Matrix Scientific | 044055 | Methyl 3-(benzoylamino)-6-methyl-2-oxo-2H-pyran-5-carboxylate >95% | 5g | $524 | 2021-12-16 | Buy |
Properties
Melting point :170-173°C
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|